These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 36332588)

  • 41. Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff.
    Andraka-Christou B; Atkins D
    Am J Drug Alcohol Abuse; 2020 Nov; 46(6):749-760. PubMed ID: 32969757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines.
    Calcaterra SL; Bottner R; Martin M; Englander H; Weinstein ZM; Weimer MB; Lambert E; Ronan MV; Huerta S; Zaman T; Ullal M; Peterkin AF; Torres-Lockhart K; Buresh M; O'Brien MT; Snyder H; Herzig SJ
    J Hosp Med; 2022 Sep; 17(9):679-692. PubMed ID: 35880821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use.
    Xu KY; Mintz CM; Presnall N; Bierut LJ; Grucza RA
    JAMA Netw Open; 2022 May; 5(5):e2211363. PubMed ID: 35536575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medication-Assisted Treatment for Opioid-Use Disorder.
    Oesterle TS; Thusius NJ; Rummans TA; Gold MS
    Mayo Clin Proc; 2019 Oct; 94(10):2072-2086. PubMed ID: 31543255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review.
    Mackey K; Veazie S; Anderson J; Bourne D; Peterson K
    J Gen Intern Med; 2020 Dec; 35(Suppl 3):954-963. PubMed ID: 33145687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review.
    Frost MC; Lampert H; Tsui JI; Iles-Shih MD; Williams EC
    Addict Sci Clin Pract; 2021 Oct; 16(1):62. PubMed ID: 34635170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review of medication-assisted treatment for opioid use disorder.
    Ghanem N; Dromgoole D; Hussein A; Jermyn RT
    J Osteopath Med; 2022 Mar; 122(7):367-374. PubMed ID: 35285220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural and organizational factors shaping access to medication treatment for opioid use disorder in community supervision.
    Kennedy-Hendricks A; Bandara S; Merritt S; Barry CL; Saloner B
    Drug Alcohol Depend; 2021 Sep; 226():108881. PubMed ID: 34218008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter.
    Tofighi B; El Shahawy O; Segoshi A; Moreno KP; Badiei B; Sarker A; Krawczyk N
    J Addict Dis; 2021; 39(1):37-45. PubMed ID: 32835641
    [No Abstract]   [Full Text] [Related]  

  • 51. Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.
    Krawczyk N; Mojtabai R; Stuart EA; Fingerhood M; Agus D; Lyons BC; Weiner JP; Saloner B
    Addiction; 2020 Sep; 115(9):1683-1694. PubMed ID: 32096302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.
    Chalhoub RM; Kalivas PW
    Drugs; 2020 Oct; 80(15):1509-1524. PubMed ID: 32776315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol.
    Dennis BB; Naji L; Bawor M; Bonner A; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Samaan Z; Thabane L
    Syst Rev; 2014 Sep; 3():105. PubMed ID: 25239213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost effectiveness of buprenorphine vs. methadone for pregnant people with opioid use disorder.
    Robin AM; Hersh AR; John C; Caughey AB
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):4918-4926. PubMed ID: 33455473
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
    Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tianeptine as an opiate replacement in a patient on methadone treatment: A case report.
    Velagapudi V; Calabrese J; Sethi R
    J Opioid Manag; 2024; 20(1):87-91. PubMed ID: 38533719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systematic review on the clinical management of chronic pain and comorbid opioid use disorder.
    Jiménez-Fernández B; Calomarde-Gómez C; López-Lazcano A; Lligoña A; Gual A; López-Pelayo H
    Adicciones; 2023 Jul; 35(2):197-212. PubMed ID: 35472158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integration of care for HIV and opioid use disorder.
    Oldfield BJ; Muñoz N; McGovern MP; Funaro M; Villanueva M; Tetrault JM; Edelman EJ
    AIDS; 2019 Apr; 33(5):873-884. PubMed ID: 30882491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of treatment duration on mortality among Veterans with opioid use disorder in the United States Veterans Health Administration.
    Ching JH; Owens DK; Trafton JA; Goldhaber-Fiebert JD; Salomon JA
    Addiction; 2021 Dec; 116(12):3494-3503. PubMed ID: 33999485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.